Moderna and Merck shares soar on mRNA cancer vaccine - Axios

Moderna and Merck shares soar on mRNA cancer vaccine Axios Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar CNBC New mRNA vaccine could reduce the recurrence and spread of skin cancer NPR Moderna’s 177% Surge Burns Shorts in ‘Painful’ $5.5 Billion Loss Bloomberg.com Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters